-The Financial Express Besides better yield, mechanisation leads to a rise in labour employment   India is known as the land of agriculture, with a holding of nearly 157 million hectares of cultivable land, making our country the second-largest agricultural landholder in the world. With over 58% of the country's population depending on agriculture for earning livelihood, it is also the biggest employment avenue in the country. The Indian Green Revolution is regarded as...

-FirstPost.com Uncertainty over the supply of subsidised foodgrain to over 19 lakh families in Assam whose livelihoods are linked to work in the tea gardens is threatening to not only spark dissent among workers but has got the industry leaders worried. To understand the impact, consider the case of Deepak Daori and Monica Daori - both workers at Mokalbari Tea Estate in Dibrugarh district. "We are worried that the our monthly ration might...

-FAO Spotlight turns to humanity's silent ally and the risks it faces Rome: Healthy soils are critical for global food production, but we are not paying enough attention to this important "silent ally," FAO Director-General José Graziano da Silva said on the eve of World Soil Day, to be celebrated on 5 December. Healthy soils not only are the foundation for food, fuel, fibre and medical products, but also are essential to...

-Business Standard Domestic regulators need to be stricter about quality violations to protect both Indian pharma exports as well as the country's image Even as major Indian drug companies continue to make news for impurities in the medicines they make and faulty - or if the USFDA is to be believed, falsified - data that many generate after testing of samples show quality problem, it seems strange that domestic authorities are silent...

-The Telegraph Regulators in several European countries are suspending marketing approval for 25 generic drugs because of concerns over the quality of data from human studies conducted by an Indian contract research company, a French medical safety agency said on Friday. Drug regulators in Belgium, France, Germany and Luxembourg have decided to suspend the marketing authorisation for the generic drugs after they discovered "irregularities" in documents relating to human studies conducted by...